ACA
CBAY

Apis Capital Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Apis Capital Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-120,000
Closed -$545K – 50
2021
Q1 		$545K Hold
120,000
– – 0.5% 36
2020
Q4 		$689K Buy
+120,000
New +$908K 0.67% 32
2019
Q2 		– Sell
-110,000
Closed -$1.46M – 38
2019
Q1 		$1.46M Sell
110,000
-50,000
-31% -$532K 1.81% 13
2018
Q4 		$1.26M Buy
+160,000
New +$1.52M 1.69% 16

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return